Malaysian Organisation of Pharmaceutical Industries (MOPI) was incorporated in 1981. The members consists of all manufacturers of pharmaceutical products whose manufacturing facilities are located in Malaysia and are licensed by the Drug Control Authority, Ministry of Health, Malaysia.
It was incorporated with a membership of 8 companies and has grown to the current 42, these members are the major pharmaceutical manufacturers of the country.
MOPI represents the industry through regular engagement and dialogue with relevant government agencies, facilitates and encourages development, transfers of information domestically and internationally. Collectively, the members produce about 35% of the country’s medicine requirements.
As Malaysia became a member of PIC/S in 2002, the industry realised the need to upgrade their facilities as well as improve the quality of their workforce through training. SeerPharma Singapore was appointed to work with MOPI to meet their training needs. SeerPharma has since been conducting regular PIC/S GMP training for the more than 10 years. Progressively, the number of topics covered annually have also expanded from 8 at the start to 16 to date.
The training content remains relevant and has been updated regularly to meet the needs and requirements of the industry and regulations. The content of the topics are endorsed by the regulators as the regulators also attend these organised workshops.
Contact us to discuss your particular GMP training requirements and learn how we can help you.
This post comes from our October 2015 Journal. You may also be interested in this post:
